Congress Pushes US FDA On Trial Diversity, Accelerated Approval In Approps Report

 
• By Sarah Karlin-Smith
colorful ropes joining together
Congress again raises concerns about a lack of alignment among the FDA's drugs and biologics centers in its appropriations report. • Source: Shutterstock

More from Legislation

More from Pink Sheet